Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioLineRx completes treatment of first patient in Phase I/II cardiac study
This was the first patient in a Phase I/II clinical trial study that is designed to assess the safety and feasibility of BL-1040 in up to 30 patients
This was the first patient in a Phase I/II clinical trial study that is designed to assess the safety and feasibility of BL-1040 in up to 30 patients
WellPoint’s affiliated Health Plans’s decision to cover Treanda followed the FDA’s decision to grant it orphan drug status for chronic lymphocytic leukemia. WellPoint has a clinical guideline in
The emergency use authorization (EUA) mechanism was created by Congress to enable the FDA Commissioner to authorize the use of a drug that has not been approved, or
The project will explore the genetic basis of longevity and create a genetic, genealogic and medical database of the Parsi-Zoroastrian population. The Avestagenome Project takes a systems biology
The trial is studying the use of Medidur FA for the treatment of diabetic macular edema (DME). Fame is two, duplicate, double-masked, randomized, multi-center studies that are following
The completed study of 460 patients is one of two parallel Phase III clinical trials being conducted at 36 academic medical centers in the UK, Sweden, the Netherlands,
This patent was originally scheduled to expire on March 27, 2007. The interim extension was granted pursuant to a portion of the Hatch-Waxman Act that provides a process
Under the terms of the agreement, which is subject to Indian government approval, Medistem Laboratories will receive cash and equity in TriCell. TriCell will receive access to Medistem’s
Under the distribution agreement Ferring will have the exclusive right to use the Resurgex trademarks and sell the Resurgex line of products in Canada. Ferring will be responsible
Alsius intravascular temperature management (IVTM) system provides cooling and warming therapy via a computer-controlled temperature regulation system that connects to Alsius’s proprietary heat exchange catheters. The company currently